MM

Marshall Morningstar

ST Sage Therapeutics: 8 patents #8 of 25Top 35%
AA Astrazeneca Ab: 4 patents #334 of 1,971Top 20%
MIT: 3 patents #1,739 of 9,367Top 20%
TI The Broad Institute: 2 patents #240 of 760Top 35%
Harvard University: 2 patents #1,071 of 3,600Top 30%
MP Mitsubishi Tanabe Pharma: 2 patents #153 of 503Top 35%
TC Tanabe Seiyaku Co.: 1 patents #222 of 389Top 60%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
📍 Framingham, MA: #60 of 1,271 inventorsTop 5%
🗺 Massachusetts: #4,915 of 88,656 inventorsTop 6%
Overall (All Time): #188,828 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12410210 Neuroactive steroids and their methods of use Maria Jesus Blanco-Pillado, Francesco G. Salituro 2025-09-09
12264177 Neuroactive steroids and their methods of use Maria Jesus Blanco-Pillado, Francesco G. Salituro 2025-04-01
12252509 Neuroactive steroids and their methods of use Maria Jesus Blanco-Pillado, Francesco G. Salituro 2025-03-18
11999765 Neuroactive steroids and their methods of use Maria Jesus Blanco-Pillado, Francesco G. Salituro 2024-06-04
11970514 Neuroactive steroids and their methods of use Maria Jesus Blanco-Pillado, Francesco G. Salituro 2024-04-30
11912738 Neuroactive steroids and their methods of use Maria Jesus Blanco-Pillado, Francesco G. Salituro 2024-02-27
11866441 Compounds and methods for the treatment of parasitic diseases Eamon Comer, Nobutaka Kato, Bruno Melillo 2024-01-09
11643434 Neuroactive steroids and compositions thereof Francesco G. Salituro, Maria Jesus Blanco-Pillado 2023-05-09
11634453 Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disorders Maria Jesus Blanco-Pillado, Francesco G. Salituro 2023-04-25
11174260 Compounds and methods for the treatment of parasitic diseases Eamon Comer, Nobutaka Kato, Bruno Melillo 2021-11-16
8124602 Compounds for the treatment of multi-drug resistant bacterial infections Gloria Anne Breault, Charles Joseph Eyermann, Bolin Geng, Folkert Reck 2012-02-28
7875715 Compounds for the treatment of multi-drug resistant bacterial infections Gloria Anne Breault, Charles Joseph Eyermann, Bolin Geng, Folkert Reck 2011-01-25
7375128 Inhibitors of α1 β2 integrin mediated cell adhesion Ila Sircar, Masatoshi Kakushima, Hidefumi Kaji, Takayuki Kawaguchi, Toshiyuki Kume 2008-05-20
7371757 Fused heterocycles as inhibitors of glutamate racemase(MURI) Gregory Steven Basarab, Charles Joseph Eyermann, Madhu Gowravaram, Oluyinka Green, Andrew Kiely +2 more 2008-05-13
7342012 Inhibitors of αLβ2 mediated cell adhesion Ila Sircar, Paul Furth, Bradley Teegarden, Nicholas Smith, Ronald C. Griffith 2008-03-11
7285558 Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections Gregory Steven Basarab, Joseph Eyermann, Madhusudhan Reddy Gowravaram, Oluyinka Green, Lawrence MacPherson +1 more 2007-10-23
7169611 Programmable genotoxic agents and uses therefor John M. Essigmann, Robert G. Croy, Kevin J. Yarema 2007-01-30
6897225 Inhibitors of αLβ2 mediated cell adhesion Ila Sircar, Paul Furth, Nicholas Smith, Bradley Teegarden, Ronald C. Griffith 2005-05-24
6894068 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase Christopher J. Michejda, Thomas Roth 2005-05-17
6500669 Programmable genotoxic agents and uses therefor John M. Essigmann, Robert G. Croy, Kevin J. Yarema 2002-12-31
6369235 Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection Christopher J. Michejda, Thomas Roth 2002-04-09
5879917 Programmable genotoxic agents and uses therefor John M. Essigmann, Robert G. Croy, Kevin J. Yarema 1999-03-09